79 related articles for article (PubMed ID: 8640146)
1. [Efficacy and tolerance of allergenic extracts Allergovit and Novo-Helisen depot in immunotherapy of allergic diseases].
Chyrek-Borowska S; Rogalewska A; Szymański W; Złotnik I; Michalska I
Pneumonol Alergol Pol; 1995; 63 Suppl 2():32-41. PubMed ID: 8640146
[TBL] [Abstract][Full Text] [Related]
2. [Allergen specific-IgG4 in circulating immune complexes in patients with inhalant allergy undergoing specific immunotherapy].
Rogala B; Jarzab J; Rymarczyk B; Tłuczykont B
Wiad Lek; 2004; 57(3-4):123-30. PubMed ID: 15307518
[TBL] [Abstract][Full Text] [Related]
3. [An immunologic evaluation of Polish pollen extract Catalet "C" and Catalet "D" in patients with pollinosis].
Chyrek-Borowska S; Szymański W; Rogalewska A; Michalska I
Pneumonol Alergol Pol; 1995; 63 Suppl 2():19-24. PubMed ID: 8640144
[TBL] [Abstract][Full Text] [Related]
4. [The influence of a three-year preseasonal specific immunotherapy on selected parameters of allergic inflammation in pollinosis patients].
Fal AM; Gietkiewicz K; Obojski A; Medrala W; Małolepszy J
Pneumonol Alergol Pol; 2002; 70(1-2):78-86. PubMed ID: 12148181
[TBL] [Abstract][Full Text] [Related]
5. Effect of allergen-specific immunotherapy on plasma level of platelet factor 4 (PF-4) and beta-thromboglobulin (beta-TG), platelet activation markers in patients with house dust mite allergy.
Kasperska-Zajac A; Brzoza Z; Rogala B
Vaccine; 2007 May; 25(18):3595-8. PubMed ID: 17291641
[TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation of Polish allergen extracts Catalet C and Catalet D in patients with pollinosis].
Szymański W; Rogalewska A; Złotnik I; Obrzut D; Chyrek-Borowska S
Pneumonol Alergol Pol; 1995; 63 Suppl 2():25-31. PubMed ID: 8640145
[TBL] [Abstract][Full Text] [Related]
7. [Eosinophil cationic protein in children with allergic diseases of the respiratory tract in exacerbation and remission of symptoms].
Marciniak D; Tomaszewicz-Fryca J; Płusa T; Chciałowski A
Pol Merkur Lekarski; 1998 Feb; 4(20):75-7. PubMed ID: 9591438
[TBL] [Abstract][Full Text] [Related]
8. [Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients].
Wang HY; Lin XP; Hao CL; Zhang CQ; Sun BQ; Zheng JP; Chen P; Sheng JY; Wu A; Zhong NS
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):679-87. PubMed ID: 17129496
[TBL] [Abstract][Full Text] [Related]
9. [Results of specific immunotherapy with Allergovit in patients with pollen allergy].
Hofman T
Pol Merkur Lekarski; 1997 Oct; 3(16):183-6. PubMed ID: 9461727
[TBL] [Abstract][Full Text] [Related]
10. Blocking antibody is generated in allergic rhinitis patients during specific immunotherapy using standardized Japanese cedar pollen extract.
Kawakami A; Koketsu R; Suzukawa M; Nagao M; Hiraguchi Y; Tokuda R; Fujisawa T; Nagase H; Ohta K; Yamamoto K; Yamaguchi M
Int Arch Allergy Immunol; 2008; 146 Suppl 1():54-60. PubMed ID: 18504408
[TBL] [Abstract][Full Text] [Related]
11. Depigmented and polymerised house dust mite allergoid: allergen content, induction of IgG4 and clinical response.
Gallego MT; Iraola V; Himly M; Robinson DS; Badiola C; García-Robaina JC; Briza P; Carnés J
Int Arch Allergy Immunol; 2010; 153(1):61-9. PubMed ID: 20357486
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of a cluster specific immunotherapy in children with bronchial asthma and mite allergy.
Schubert R; Eickmeier O; Garn H; Baer PC; Mueller T; Schulze J; Rose MA; Rosewich M; Renz H; Zielen S
Int Arch Allergy Immunol; 2009; 148(3):251-60. PubMed ID: 18849616
[TBL] [Abstract][Full Text] [Related]
13. An observational study on outgrowing food allergy during non-birch pollen-specific, subcutaneous immunotherapy.
Alonso R; Enrique E; Pineda F; Basagaña M; San Miguel-Moncín MM; Bartra J; Palacios R; Cisteró-Bahíma A
Int Arch Allergy Immunol; 2007; 143(3):185-9. PubMed ID: 17284927
[TBL] [Abstract][Full Text] [Related]
14. [Results of immunotherapy with Allergovit preparation of the Allergopharma Company in patients with hypersensitivity to pollen].
Hofman T; Kolasińska B
Pol Merkur Lekarski; 1996 Jul; 1(1):41-2. PubMed ID: 9156891
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of sublingual coseasonal immunotherapy with a monomeric allergoid in Cupressaceae pollen allergy--preliminary data.
Ariano R; Panzani RC; Mistrello G
Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):103-8. PubMed ID: 15918297
[TBL] [Abstract][Full Text] [Related]
16. [The effect of specific immunotherapy on serum eotaxin level in patients with pollinosis: preliminary studies].
Jahnz-Rózyk K; Głodzińska-Wyszogrodzka E; Rozyńska-Polańska R; Paluchowska E; Zabielski LS
Pol Merkur Lekarski; 2001 Sep; 11(63):244-6. PubMed ID: 11761820
[TBL] [Abstract][Full Text] [Related]
17. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the efficacy of immunotherapy with allergovit and catalet in patients with hay fever--multidrug evaluations].
Hofman T; Buczyłko K; Brewczyński P; Kolasińska B
Pneumonol Alergol Pol; 1997; 65(1-2):65-70. PubMed ID: 9289305
[TBL] [Abstract][Full Text] [Related]
19. [Cluster-immunotherapy in seasonal allergic rhinitis: safety aspects of induction therapy with depot allergoids (Purethal)].
Hansen I; Hörmann K; Stuck BA; Schneider-Gêne S; Mösges R; Klimek L
Laryngorhinootologie; 2003 Aug; 82(8):558-63. PubMed ID: 12915987
[TBL] [Abstract][Full Text] [Related]
20. Specific immunotherapy in atopic dermatitis--Four-year treatment in different age and airborne allergy type subgroups.
Czarnecka-Operacz M; Silny W
Acta Dermatovenerol Croat; 2006; 14(4):230-240. PubMed ID: 17328144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
